Response to Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412-2421.
Saved in:
| Title: | Response to Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45:2412-2421. |
|---|---|
| Authors: | Serés-Noriega T; 1Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic de Barcelona, Barcelona, Spain., Boswell L; 1Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic de Barcelona, Barcelona, Spain.; 2Endocrinology and Nutrition Department, Althaia University Health Network, Manresa, Spain., Perea V; 3Endocrinology and Nutrition Department, Hospital Universitari Mútua de Terrassa, Terrassa, Spain., Amor AJ; 1Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic de Barcelona, Barcelona, Spain. |
| Source: | Diabetes care [Diabetes Care] 2023 Mar 01; Vol. 46 (3), pp. e87-e88. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't; Comment |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1935-5548 |
|---|---|
| DOI: | 10.2337/dci22-0061 |
